BioTelemetry, Inc. (NASDAQ: BEAT) received the Food and Drug Administration's approval for its next generation Mobile Cardiac Outpatient Telemetry device, the MCOT Patch. According to the company, the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced new research evaluating mobile cardiac outpatient telemetry (MCOT) as a ...
As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder alone Almost eight times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results